{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:10:17Z","timestamp":1767913817058,"version":"3.49.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074111","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T17:20:17Z","timestamp":1377883217000},"page":"e74111","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Subcutaneous Interferon \u03b2-1a May Protect against Cognitive Impairment in Patients with Relapsing\u2013Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Francesco","family":"Patti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo Brescia","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trojano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Bastianello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosalia","family":"Tola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cottone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Plant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orietta","family":"Picconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"COGIMUS Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00019052-199506000-00010","article-title":"Neuropsychology of multiple sclerosis","volume":"8","author":"SM Rao","year":"1995","journal-title":"Curr Opin Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1352458508096684","article-title":"Cognitive impairment in multiple sclerosis","volume":"15","author":"F Patti","year":"2009","journal-title":"Mult Scler"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.2004.045518","article-title":"Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves","volume":"76","author":"A Achiron","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jocn.2007.02.006","article-title":"Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations","volume":"14","author":"JM Rogers","year":"2007","journal-title":"J Clin Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1191\/1352458505ms1182oa","article-title":"The association between cognitive impairment and physical disability in multiple sclerosis","volume":"11","author":"SG Lynch","year":"2005","journal-title":"Mult Scler"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","article-title":"Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years","volume":"58","author":"MP Amato","year":"2001","journal-title":"Arch Neurol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning","volume":"41","author":"SM Rao","year":"1991","journal-title":"Neurology"},{"key":"ref8","unstructured":"Ruet A, Deloire M, Hamel D, Ouallet JC, Petry K, <etal>et al<\/etal>.. (2012) Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study. J Neurol Oct 19 [Epub ahead of print]: 10.1007\/s00415-012-6705-1."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2005.09.015","article-title":"Cognitive fatigue in multiple sclerosis: findings from a two-wave screening project","volume":"245","author":"Y Barak","year":"2006","journal-title":"J Neurol Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/YCO.0b013e3280eb10d7","article-title":"The neuropsychiatry of multiple sclerosis: a review of recent developments","volume":"20","author":"O Ghaffar","year":"2007","journal-title":"Curr Opin Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00023210-200216070-00002","article-title":"Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management","volume":"16","author":"B Bagert","year":"2002","journal-title":"CNS Drugs"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.07.017","article-title":"Are there protective treatments for cognitive decline in MS?","volume":"245","author":"MP Amato","year":"2006","journal-title":"J Neurol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1517\/13543784.2012.716036","article-title":"Treatment of cognitive impairment in patients with multiple sclerosis","volume":"21","author":"F Patti","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1517\/14656566.7.1.S1","article-title":"Disease-modifying drugs for multiple sclerosis: current and future aspects","volume":"7","author":"MS Freedman","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/1352458506070933","article-title":"The Rao&apos;s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population","volume":"12","author":"MP Amato","year":"2006","journal-title":"Mult Scler"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1352458509350309","article-title":"Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis","volume":"16","author":"F Patti","year":"2010","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1177\/1352458509105544","article-title":"Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study","volume":"15","author":"F Patti","year":"2009","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.56.12.1628","article-title":"PRISMS-4: long-term efficacy of interferon-beta-1a in relapsing MS","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/jnnp.2010.213744","article-title":"Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis","volume":"82","author":"F Reuter","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp.2010.237834","article-title":"Cognitive deterioration in patients with early multiple sclerosis: a 5-year study","volume":"83","author":"BI Glanz","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/1352458508089686","article-title":"Memory decline evolves independently of disease activity in MS","volume":"14","author":"B Duque","year":"2008","journal-title":"Mult Scler"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","article-title":"Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis","volume":"66","author":"M Calabrese","year":"2009","journal-title":"Arch Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/1352458510394702","article-title":"Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis","volume":"18","author":"M Calabrese","year":"2012","journal-title":"Mult Scler"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2005.09.005","article-title":"Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy","volume":"118","author":"M Caggiula","year":"2006","journal-title":"Clin Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1177\/1352458511399797","article-title":"The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment","volume":"17","author":"S Lindquist","year":"2011","journal-title":"Mult Scler"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","volume":"71","author":"A Alonso","year":"2008","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9343(94)90173-2","article-title":"Age and sex associations of 40 autoimmune diseases","volume":"96","author":"PB Beeson","year":"1994","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jnnp.67.2.148","article-title":"Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors","volume":"67","author":"SA Hawkins","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process","volume":"126","author":"C Confavreux","year":"2003","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1468-1331.2003.00519.x","article-title":"\u2018Gender gap\u2019 in multiple sclerosis: magnetic resonance imaging evidence","volume":"10","author":"C Pozzilli","year":"2003","journal-title":"Eur J Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004150070179","article-title":"A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis","volume":"247","author":"SJ Weatherby","year":"2000","journal-title":"J Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.72.2.184","article-title":"HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis","volume":"72","author":"AE Hensiek","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0022-510X(00)00389-0","article-title":"Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis","volume":"178","author":"EG Celius","year":"2000","journal-title":"J Neurol Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2003.033324","article-title":"Sex hormones modulate brain damage in multiple sclerosis: MRI evidence","volume":"76","author":"V Tomassini","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2012.01.001","article-title":"Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender","volume":"33","author":"M Kipp","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis","volume":"339","author":"C Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"S Vukusic","year":"2004","journal-title":"Brain"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2009.06.036","article-title":"Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment","volume":"286","author":"M Trojano","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1352458510384605","article-title":"Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients","volume":"17","author":"RA Rudick","year":"2011","journal-title":"Mult Scler"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/brain\/120.2.289","article-title":"The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up","volume":"120","author":"P Kujala","year":"1997","journal-title":"Brain"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(04)17271-1","article-title":"Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial","volume":"364","author":"M Filippi","year":"2004","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:45:06Z","timestamp":1540021506000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074111"}},"subtitle":[],"editor":[{"given":"Pablo","family":"Villoslada","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074111","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}